UNASSIGNED: The available research on T2D and the use of DSME in LMIC were systematically searched for using six electronic databases (PubMed, Embase, Cochrane, Web of Science, Google Scholar, PAIS, and EBSCO Discovery) between the months of October and November of 2022. The articles that met the search criteria were subsequently imported into EndNote and Covidence for analysis. The Cochrane RoB methodology for randomized trials was used to evaluate the risk of bias (RoB) in the included studies. A narrative synthesis was used to summarize the results.
UNASSIGNED: A total of 773 studies were imported for screening, after 203 duplicates were removed, 570 remained. Abstract and title screenings resulted in the exclusion of 487 articles, leaving 83 for full-text review. Following a full-text review, 76 articles were excluded and seven were found to be relevant to our search. The most common reasons for exclusion were study design (n = 23), lack of results (n = 14), and wrong patient population (n = 12).
UNASSIGNED: Our systemic review found that DSME can be an acceptable and cost-effective solution in LMIC. While we intended to analyze cost, adoption, acceptability, and fidelity, our investigation revealed a gap in the literature on those areas, with most studies focusing on acceptability and cost and no studies identifying fidelity or adoption. To further evaluate the efficacy of DSME and enhance health outcomes for T2D in LMICs, more research is needed on its application.
UNASSIGNED: osf.io/7482t.
■使用六个电子数据库(PubMed,Embase,科克伦,WebofScience,谷歌学者,PAIS,和EBSCO发现)在2022年10月至11月之间。符合搜索标准的文章随后被导入到EndNote和Covidence中进行分析。随机试验的CochraneRoB方法用于评估纳入研究的偏倚风险(RoB)。使用叙述性综合来总结结果。
■共有773项研究被输入用于筛查,在删除了203个重复项之后,570只剩下摘要和标题筛选导致487篇文章被排除在外,留下83供全文审查。经过全文审查,76篇文章被排除在外,发现7篇文章与我们的搜索相关。排除的最常见原因是研究设计(n=23),缺乏结果(n=14),和错误的患者群体(n=12)。
■我们的系统审查发现,DSME可以是LMIC中可接受且具有成本效益的解决方案。虽然我们打算分析成本,收养,可接受性,和忠诚,我们的调查显示,在这些领域的文献中存在差距,大多数研究侧重于可接受性和成本,没有研究确定保真度或采用率。为了进一步评估DSME的疗效并增强LMIC中T2D的健康结果,它的应用还需要更多的研究。
■osf.io/7482t。